David Strege, MD
Hand Surgery · Saint Louis, MONPI 1316974439
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,244 of the $3,945 with a category attached, or 82.2%. 18 manufacturers reported payments, led by Arthrex at 50.4% of the total. Reporting peaked in 2019 at $3,304 and has fallen 97.7% since, to $76 in 2025. That places this record below the midpoint for hand surgery clinicians in MO, where the typical reported total is $4,263.
Across 33 payments — averaging $119.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Elite Orthopedics, LLC$1K
- Endo Pharmaceuticals Inc.$172
- Highridge Medical LLC$87
- Endo USA, Inc.$76
- Zimvie Inc.$46
- plus $231 from 12 others
What the payments were for
- Food & beverage$70118%
- Education$3,24482%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $1,990 |
| Elite Orthopedics, LLC | 3 | $1,343 |
| Endo Pharmaceuticals Inc. | 8 | $172 |
| Highridge Medical LLC | 2 | $87 |
| Endo USA, Inc. | 3 | $76 |
| Zimvie Inc. | 2 | $46 |
| Stryker | 1 | $25 |
| EBI, LLC | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $23 |
| KCI USA, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Davol Inc. | 1 | $21 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $20 |
| Smith+Nephew | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Sonex Health, Inc. | 1 | $12 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
How this compares
$3,945 in reported general payments places this provider in the 45th percentile of 36 hand surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 118 | $831 |
| Meloxicam | 80 | $218 |
| Diclofenac Sodium | 16 | $198 |
| Cefadroxil | 11 | $108 |
| Tramadol Hcl | 18 | $61 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Saint Louis
- Richard GelbermanSaint Louis$30K
- Tyler KrummenacherSaint Louis$26K
- Wassim MouradSaint Louis$24K
- Robert BellSaint Louis$20K
- Matthew WintertonSaint Louis$10K
- Nathan FisherSaint Louis$10K
- Nathanael OlsonSaint Louis$9K
- Schuyler HalversonSaint Louis$8K
- William FeinsteinSaint Louis$6K
- Colleen GlissonSaint Louis$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.